Rockwell Medical

FDA approves Rockwell Medical's iron replacement drug
FDA approves Rockwell Medical's iron replacement drug
Yahoo/Reuters
FDA
Rockwell Medical
Triferic
chronic kidney disease
Flag link:
Biotech Stocks Make Big Moves In Final Days Of 2014
Biotech Stocks Make Big Moves In Final Days Of 2014
Yahoo/Benzinga
NeuroDerm
Arrowhead Research
Rockwell Medical
Redhill Biopharma
Cytokinetics
NephroGenex
Flag link:
Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.
Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.
TheStreet.com
Rockwell Medical
dialysis
FDA
advisory panels
devices
Flag link:
FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need
FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need
TheStreet.com
Rockwell Medical
devices
dialysis
Triferic
FDA
Flag link:
Baxter Gets Shot In The Arm From Rockwell Deal
Baxter Gets Shot In The Arm From Rockwell Deal
Investor's.com
Baxter
Rockwell Medical
Flag link:
Today’s Top Biotech Stories: Albany Molecular Research, Rockwell Medical, and Celgene
Today’s Top Biotech Stories: Albany Molecular Research, Rockwell Medical, and Celgene
Motley Fool
Albany Molecular Research
Rockwell Medical
Celgene
Cedarburg Pharmaceuticals
Triferic
Otezla
Flag link:
Rockwell Medical: Significant Growth Potential With New State-Of-The-Art Dialysis Drug
Rockwell Medical: Significant Growth Potential With New State-Of-The-Art Dialysis Drug
Seeking Alpha
Rockwell Medical
dialysis
Soluble Ferric Pyrophosphate
Flag link:
Rockwell Medical Inc: SFP's Market Potential
Rockwell Medical Inc: SFP's Market Potential
Seeking Alpha
Rockwell Medical
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
Astex
Otsuka
Rockwell Medical
Theravance
GSK
Cytokinetics
Amgen
Flag link:
Rockwell Medical: Expecting Good Cruise II Data In September
Rockwell Medical: Expecting Good Cruise II Data In September
Seeking Alpha
Rockwell Medical
Calcitriol
generics
dialysis
SFP
Flag link:
Rockwell Medical: Undervalued After CRUISE-1 Results
Rockwell Medical: Undervalued After CRUISE-1 Results
Seeking Alpha
Rockwell Medical
chronic kidney disease
Soluble Ferric Pyrophosphate
Flag link:
Rockwell Medical's iron deficiency drug succeeds in trial
Rockwell Medical's iron deficiency drug succeeds in trial
Reuters
Rockwell Medical
Iron Deficiency
SFP
Flag link:
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
Seeking Alpha
Rockwell Medical
chronic kidney disease
Flag link:
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Flag link:
4 Biotech Stocks Offering Potential, Pipeline And Price
4 Biotech Stocks Offering Potential, Pipeline And Price
Seeking Alpha
Vical
Rockwell Medical
Cytokinetics
Labstyle Innovations
Flag link:
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Seeking Alpha
Rockwell Medical
Soluble Ferric Pyrophosphate
renal disease
Flag link:
Rockwell Medical Reports Third Quarter 2012 Results
Rockwell Medical Reports Third Quarter 2012 Results
Rockwell Medical
earnings
Flag link:
Rockwell Medical Reports Second Quarter 2012 Results
Rockwell Medical Reports Second Quarter 2012 Results
Rockwell Medical
earnings
Flag link:
Rockwell Medical Announces Canadian Patent Issuance for Proprietary SFP-Iron Delivery
Rockwell Medical Announces Canadian Patent Issuance for Proprietary SFP-Iron Delivery
Rockwell Medical
Canada
patent
Flag link:
Rockwell Medical Data Safety Monitoring Board Recommends SFP Phase III Efficacy Studies to Continue as Planned
Rockwell Medical Data Safety Monitoring Board Recommends SFP Phase III Efficacy Studies to Continue as Planned
Rockwell Medical
safety
Flag link:

Pages